Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Related Citations for PubMed (Select 23921876)

1.

Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events.

Kharbanda EO, Vazquez-Benitez G, Lipkind H, Naleway A, Lee G, Nordin JD; Vaccine Safety Datalink Team.

Obstet Gynecol. 2013 Sep;122(3):659-67. doi: 10.1097/AOG.0b013e3182a1118a.

PMID:
23921876
2.

Maternal safety of trivalent inactivated influenza vaccine in pregnant women.

Nordin JD, Kharbanda EO, Benitez GV, Nichol K, Lipkind H, Naleway A, Lee GM, Hambidge S, Shi W, Olsen A.

Obstet Gynecol. 2013 Mar;121(3):519-25. doi: 10.1097/AOG.0b013e3182831b83.

PMID:
23635613
3.

Maternal influenza vaccine and risks for preterm or small for gestational age birth.

Nordin JD, Kharbanda EO, Vazquez Benitez G, Lipkind H, Vellozzi C, Destefano F; Vaccine Safety Datalink.

J Pediatr. 2014 May;164(5):1051-1057.e2. doi: 10.1016/j.jpeds.2014.01.037. Epub 2014 Feb 26.

PMID:
24582484
4.

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L, Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR, Belongia E, Nordin J, Chen RT, Shay DK, Davis RL, DeStefano F; Vaccine Safety Datalink Team.

JAMA. 2006 Oct 25;296(16):1990-7.

PMID:
17062862
5.

Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events.

Nordin JD, Kharbanda EO, Vazquez-Benitez G, Lipkind H, Lee GM, Naleway AL.

Vaccine. 2014 Sep 3;32(39):4985-92. doi: 10.1016/j.vaccine.2014.07.017. Epub 2014 Jul 18.

PMID:
25045808
6.

Safety of influenza vaccination during pregnancy: a review of subsequent maternal obstetric events and findings from two recent cohort studies.

Naleway AL, Irving SA, Henninger ML, Li DK, Shifflett P, Ball S, Williams JL, Cragan J, Gee J, Thompson MG; Vaccine Safety Datalink and Pregnancy and Influenza Project.

Vaccine. 2014 May 30;32(26):3122-7. doi: 10.1016/j.vaccine.2014.04.021. Epub 2014 Apr 14. Review.

PMID:
24742490
7.

Trivalent inactivated influenza vaccine and spontaneous abortion.

Irving SA, Kieke BA, Donahue JG, Mascola MA, Baggs J, DeStefano F, Cheetham TC, Jackson LA, Naleway AL, Glanz JM, Nordin JD, Belongia EA; Vaccine Safety Datalink.

Obstet Gynecol. 2013 Jan;121(1):159-65. doi: http://10.1097/AOG.0b013e318279f56f.

PMID:
23262941
8.

Seasonal influenza vaccines.

Fiore AE, Bridges CB, Cox NJ.

Curr Top Microbiol Immunol. 2009;333:43-82. doi: 10.1007/978-3-540-92165-3_3. Review.

PMID:
19768400
9.

Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial.

Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, Watts M, Kozinetz C, Hessel C, Glezen WP.

Pediatrics. 2005 Sep;116(3):e397-407.

10.

Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.

Glanz JM, Newcomer SR, Hambidge SJ, Daley MF, Narwaney KJ, Xu S, Lee GM, Baggs J, Klein NP, Nordin JD, Naleway AL, Belongia EA, Weintraub ES.

Arch Pediatr Adolesc Med. 2011 Aug;165(8):749-55. doi: 10.1001/archpediatrics.2011.112.

PMID:
21810637
11.

Vaccines for preventing influenza in people with asthma.

Cates CJ, Rowe BH.

Cochrane Database Syst Rev. 2013 Feb 28;2:CD000364. doi: 10.1002/14651858.CD000364.pub4. Review.

PMID:
23450529
12.

Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.

Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, Vellozzi C, Yih WK, Gellin B, Lurie N; H1N1 GBS Meta-Analysis Working Group.

Lancet. 2013 Apr 27;381(9876):1461-8. doi: 10.1016/S0140-6736(12)62189-8. Epub 2013 Mar 13.

PMID:
23498095
13.

Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine.

Schmidt MA, Crane B, Mullooly JP, Naleway AL.

Vaccine. 2010 Nov 16;28(49):7713-5. doi: 10.1016/j.vaccine.2010.09.043. Epub 2010 Sep 25.

PMID:
20875495
14.

Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

Wharton M, Strikas RA, Harpaz R, Rotz LD, Schwartz B, Casey CG, Pearson ML, Anderson LJ; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee.

MMWR Recomm Rep. 2003 Apr 4;52(RR-7):1-16.

15.
16.

Trivalent inactivated influenza vaccine is not associated with sickle cell crises in children.

Hambidge SJ, Ross C, Glanz J, McClure D, Daley MF, Xu S, Shoup JA, Narwaney K, Baggs J, Weintraub E; Vaccine Safety Datalink Team.

Pediatrics. 2012 Jan;129(1):e54-9. doi: 10.1542/peds.2011-1294. Epub 2011 Dec 12.

17.

Influenza vaccine for patients with chronic obstructive pulmonary disease.

Poole PJ, Chacko E, Wood-Baker RW, Cates CJ.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD002733. Review.

PMID:
16437444
18.

Effect of influenza vaccination in the first trimester of pregnancy.

Sheffield JS, Greer LG, Rogers VL, Roberts SW, Lytle H, McIntire DD, Wendel GD Jr.

Obstet Gynecol. 2012 Sep;120(3):532-7. doi: 10.1097/AOG.0b013e318263a278.

PMID:
22914461
19.

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults.

Greenberg DP, Robertson CA, Noss MJ, Blatter MM, Biedenbender R, Decker MD.

Vaccine. 2013 Jan 21;31(5):770-6. doi: 10.1016/j.vaccine.2012.11.074. Epub 2012 Dec 8.

PMID:
23228813
20.

Effectiveness and safety of pandemic influenza A (H1N1) 2009 vaccine in healthcare workers at a university hospital in Japan.

Igari H, Watanabe A, Chiba H, Shoji K, Segawa S, Nakamura Y, Watanabe M, Suzuki K, Sato T.

Jpn J Infect Dis. 2011;64(3):177-82.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk